Spain adds 38,118 new infections and 513 deaths with the incidence rate falling for the second consecutive day

The Ministry of Health has registered 38,118 new cases of coronavirus in the last day, while the number of new positives reported yesterday was 34,899. Regarding the deceased, the balance of this Thursday leaves 513 new fatalities related to COVID-19, bringing the total to 58,319. The cumulative incidence at 14 days, which yesterday registered a slight decrease (to 889.93 cases per 100,000 inhabitants) for the first time after weeks of increase, it continues to decline and stands today at 886.67 cases.

By territories, the Valencian Community continues to be the one with the most cases this Friday with 8,024 new positives. After it, Andalusia notifies 7,703; Madrid, 5,438 and Catalunya, 4,951.

In terms of cumulative incidence, three autonomous communities with figures above 1,300 cases are of particular concern: the Valencian Community (1,431.28), Castilla y León (1,402.89) and La Rioja (1,347.23). However, in all of them there is a decrease compared to yesterday.

In this context, The European Medicines Agency (EMA) authorized this Friday the AstraZeneca vaccine against COVID-19 for people over 18 years of age. Now it is up to the Community Executive to give authorization for its conditional marketing, which is expected in the next few hours. Anyway, in line with the warnings of the German experts expressed this Thursday, the EMA recognizes that "the majority of the participants in the studies were between 18 and 55 years old". So they have made it clear that "there are still not enough results in older participants (over 55 years) to provide a figure on how the vaccine will work in this group."

However, the EMA has ensured that it "expects protection, given that an immune response is observed in this age group and based on experience with other vaccines". Therefore, "the EMA believes that the vaccine can be used in older adults, although more information is expected from ongoing studies, which include a higher proportion of elderly participants."


Source link